China NMPA Product Recall - SYNERGY MONORAIL Everolimus-Eluting Platinum Chromium Coronary Stent System
China NMPA product recall for SYNERGY MONORAIL Everolimus-Eluting Platinum Chromium Coronary Stent System by Boston Scientific Corporation published January 05, 2026. Recall level: Level 3 Recall. Boston Scientific Corporation initiated a voluntary Class III recall of its SYNERGY MONORAIL Everoli
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for SYNERGY MONORAIL Everolimus-Eluting Platinum Chromium Coronary Stent System by Boston Scientific Corporation published January 05, 2026. Recall level: Level 3 Recall. Boston Scientific Corporation initiated a voluntary Class III recall of its SYNERGY MONORAIL Everoli
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox